FASLG overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

FASLG overexpression	Non Small Cell Lung Cancer	FASLG overexpression	Non Small Cell Lung Cancer	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3
FASLG overexpression	Non Small Cell Lung Cancer	FASLG overexpression	Non Small Cell Lung Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3

Associations